Human papilloma virus infection and overexpression of p53 protein in bilharzial bladder cancer

被引:12
作者
Khaled, HM [1 ]
Raafat, A
Mokhtar, N
Zekri, ARN
Gaballah, H
机构
[1] Cairo Univ, Natl Canc Inst, Dept Med Oncol, Cairo 11796, Egypt
[2] Cairo Univ, Natl Canc Inst, Dept Pathol, Cairo 11796, Egypt
[3] Cairo Univ, Natl Canc Inst, Dept Virol & Immunol, Cairo 11796, Egypt
关键词
bilharziasis; bladder cancer; human papilloma virus; immunohistochemistry; in situ hybridization; p53; protein;
D O I
10.1177/030089160108700409
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aims and background: An association between human papilloma virus (HPV) and bladder cancer has been reported. However, the role of HPV in bilharzial bladder cancer and its prevalence have not yet been clarified. Study design: We investigated 50 cases for HPV types 16/18 by in situ hybridization. Also, p53 protein expression by immunohistochemistry was evaluated in 41 of the 50 cases, with correlation of these factors to clinicopathologic parameters and tumor relapse after primary treatment. Results: HPV was detected in 46% of Egyptian bladder carcinomas (23/50 cases). Positivity was 47.8% for squamous cell carcinoma and 36.4% for transitional cell carcinoma. There was a possible viral-bilharzial association as 52.8% of Bilharzial cases, whereas only 12.5% of non-Bilharzial cases were HPV positive (P < 0.05). P53 protein was found in 19/41 (46.3%) cases. There was a concordance between HPV and p53 in 58.5% of cases. Neither factor was related to tumor recurrence after primary treatment. Conclusions: HPV may thus be implicated in the etiology of bilharzial bladder cancer, but a definite causal relationship remains to be demonstrated. HPV together with p53 alterations work in synergy to accelerate the carcinogenic process, as there was concordance in the results of both parameters in 24/41 (58.5%) cases.
引用
收藏
页码:256 / 261
页数:6
相关论文
共 28 条
[1]  
ANWAR K, 1992, CANCER-AM CANCER SOC, V70, P1967, DOI 10.1002/1097-0142(19921001)70:7<1967::AID-CNCR2820700726>3.0.CO
[2]  
2-8
[3]   DETECTION OF HUMAN PAPILLOMAVIRUS DNA IN CANCER OF THE URINARY-BLADDER BY INSITU HYBRIDIZATION [J].
BRYANT, P ;
DAVIES, P ;
WILSON, D .
BRITISH JOURNAL OF UROLOGY, 1991, 68 (01) :49-52
[4]   ROLE OF PAPILLOMAVIRUSES [J].
CHANG, F .
JOURNAL OF CLINICAL PATHOLOGY, 1990, 43 (04) :269-276
[5]  
ESRIG D, 1993, AM J PATHOL, V143, P1389
[6]  
FURIHATA M, 1993, CANCER RES, V53, P4823
[7]   DETECTION OF HUMAN PAPILLOMAVIRUS DNA IN ADVANCED EPITHELIAL OVARIAN-CARCINOMA [J].
KAUFMAN, RH ;
BORNSTEIN, J ;
GORDON, AN ;
ADAM, E ;
KAPLAN, AL ;
ADLERSTORTHZ, K .
GYNECOLOGIC ONCOLOGY, 1987, 27 (03) :340-349
[8]   A comparison of different modes for the detection of p53 protein accumulation - A study of bladder cancer [J].
Kraggerud, SM ;
Jacobsen, KD ;
Berner, A ;
Stokke, T ;
Holm, R ;
Smedshammer, L ;
BorresenDale, AL ;
Fossa, SD .
PATHOLOGY RESEARCH AND PRACTICE, 1997, 193 (07) :471-478
[9]  
LARUE H, 1995, CLIN CANCER RES, V1, P435
[10]   OVER-EXPRESSION OF P53 NUCLEAR ONCOPROTEIN IN TRANSITIONAL-CELL BLADDER-CANCER AND ITS PROGNOSTIC VALUE [J].
LIPPONEN, PK .
INTERNATIONAL JOURNAL OF CANCER, 1993, 53 (03) :365-370